Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

688.60INR
17 Oct 2014
Price Change (% chg)

Rs1.95 (+0.28%)
Prev Close
Rs686.65
Open
Rs697.00
Day's High
Rs702.00
Day's Low
Rs685.00
Volume
13,043
Avg. Vol
43,175
52-wk High
Rs906.90
52-wk Low
Rs642.50

Search Stocks
IPCA Laboratories Limited is a pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs)-Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic). Its formulations basket includes generics for the developed markets and branded formulations for emerging markets. The Company manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables (liquid and dry). The Company’s subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd., Ipca Pharma Nigeria Ltd., National Druggist (PTY) Ltd and Ipca Pharma (Australia) Pty Ltd.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks